Answers are grounded in this paper and cite their sources.
Automated system achieves high liver tumor segmentation accuracy, improving diagnostic efficiency and patient outcomes.
The detection and treatment of cancerous tumors in the liver are considered one of the most challenging health issues for patients globally. There is a need for fully automated systems that can precisely detect and segment the tumorous regions in medical images. This work aims to develop an automated system which utilizes a hybrid- deep- learning framework with fusion multi-scale inception feature extraction called HSCS-NET (Hawk-Swarm Ception Segmentation Network). In the proposed model, the encoder comprises of Hawk Gating with SE (squeeze-and-excitation) attention while decoders consist of adaptive attention skip fusion which comprises of Swarm ception Residual ASPP bridges. These components allow the model to recover important details of the boundaries of the tumors irrespective to their shape, size, and the tissue contrast in CT scans.In order to improve segmentation, the HSCS-NET framework is equipped with a hybrid optimization module based on PSO (Particle Swarm Optimization) and GWO (Grey Wolf Optimization) for dynamic feature selection and reliable convergence. The model was evaluated against the 3DIRCADb1 Liver Tumor Segmentation Challenge (LiTS) dataset and significantly outperformed all other models achieving a Dice coefficient value of 0.98, Accuracy of 0.9891, and Precision of 0.9901.This marks a substantial improvement over prior models such as Christ et al.’s CNN (Dice: 0.823), Wu et al.’s Fuzzy C-means + GC (Dice: 0.83), Muhammad et al.’s ResNet (Dice: 0.87, Accuracy: 0.945, Precision: 0.93), and Kaur et al.’s PSO-PSP-Net (Accuracy: 0.9754, Precision: 0.9632).The HSCS-NET architecture is mathematically grounded, modularly extensible, and validated through rigorous cross-validation and confidence refinement. With its high segmentation performance, clinical reliability, and computational efficiency, HSCS-NET stands as a superior advancement in automated liver cancer diagnostics, reducing clinician workload and improving patient prognoses through precision imaging.
No takes yet. Share an insight, caveat, or question.
Chhabra et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: